Innovative Technology Novilytic's Proteometer offers near-real-time molecular analysis that streamlines drug development processes, presenting an opportunity to target biopharmaceutical companies seeking to reduce time and costs in R&D pipelines.

Strong Industry Collaborations Partnership with Purdue Research Foundation and recent NIH funding highlight Novilytic’s growing credibility and network, making it appealing for investors and partners interested in cutting-edge biotech innovations.

Funding & Growth With a recent $1.4M NIH grant and a seed round totaling $1.6M, Novilytic demonstrates solid financial backing, indicating potential for expansion and increased capacity to adopt new sales channels.

Market Positioning Operating within the biotech research sector with other mid-sized companies, Novilytic is positioned to attract customers in niche areas like biochemistry analytics and drug security, offering high-value solutions to life sciences firms.

Digital Presence & Tech Stack Utilizing advanced web technologies like React and Cloud CDN, Novilytic maintains a modern digital platform, making it easier for sales teams to engage prospects through digital channels and showcase their innovative offerings.